Matthew E. Korenberg
Independent DirectorMr. Matthew E. Korenberg, also known as Matt, is Chief Financial Officer of Palvella Therapeutics, Inc. from October 17, 2024 and serves as its Treasurer and Corporate Secretary. Mr. Korenberg is an Independent Director of Lifecore Biomedical, Inc. from August 2024. He served as Independent Director of Qualigen Therapeutics, Inc. since May 22, 2020 until October 03, 2024. He had been the Chief Financial Officer at Ligand Pharmaceuticals Incorporated since August 06, 2015 until November 2022 and Executive Vice President of Finance from January 2018 until November 2022 and served as its President and COO since November 2022 until October 2024. He served as Vice President of Finance at Ligand Pharmaceuticals Inc. since August 06, 2015 until January 2018. He joined Ligand in 2015 from NeuroCircuit Therapeutics, where he was founder, Chief Executive Officer and Director. Prior to NeuroCircuit Therapeutics, he was with Goldman, Sachs & Co. from July 1999 through August 2013 in its New York, London and San Francisco offices. Most recently, he served as a Managing Director in the healthcare investment banking team, where he advised and financed companies in the biotechnology and pharmaceutical industries from July 1999 through August 2013. Prior to Goldman Sachs, he was a Healthcare Investment Banker at Dillon, Read & Co. Inc. He has healthcare business experience across healthcare investing banking and operations. He has a BBA in finance and accounting from the University of Michigan.
Positions
- Company NameLifecore Biomedical, Inc.Stock CodeLFCRPositionIndependent DirectorColleagues
- PJPaul JosephsPresident, CEO & Director
- KLKatrina Lovas HoudeIndependent Chairman of the Board
- RDRyan D. LakeExecutive VP & CFO
- TDThomas D. SalusChief Legal & Administration Officer and Corporate Secretary
- TGThomas GuldagerVice President of Operations
- APAaron PerlitshChief Compliance Officer & Director of Internal Audit
- JEJoshua E. SchechterIndependent Director
- PHPaul Harold JohnsonIndependent Director
- Company NamePalvella Therapeutics, Inc.Stock CodePVLAPositionCFO, Corporate Secretary & TreasurerColleagues
- WHWesley H. KaupinenFounder, President, CEO & Director
- GMGeorge M. JenkinsIndependent Chairman of the Board
- MEMatthew E. KorenbergCFO, Corporate Secretary & Treasurer
- KGKathleen GoinChief Operating Officer
- JMJeffrey MartiniChief Scientific Officer
- MBMarcy B. NanusVice President of Investor Relations & Corporate Affairs
- TCTodd C. DavisIndependent Director
- CPChristopher P. KiritsyIndependent Director
- EJElaine J. HeronIndependent Director
